Fundação Antonio Prudente - Hospital do Câncer AC Camargo

São Paulo 01509-900

0 studies enrolling now · 3 studies all time

What they study most

HER-2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Non Small Cell Lung Cancer, Respiratory Syncytial Virus

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract — Completed